NasdaqGS - Delayed Quote USD
Aclaris Therapeutics, Inc. (ACRS)
At close: November 15 at 4:00 PM EST
After hours: November 15 at 5:13 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BALTHASER KEVIN J Chief Financial Officer | Conversion of Exercise of derivative security | Aug 30, 2024 | 24,697 |
| GOWEN MAXINE Director | Conversion of Exercise of derivative security | May 31, 2024 | 16,961 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 5, 2024 | -- |
| MEHRA ANAND Director | Conversion of Exercise of derivative security | May 31, 2024 | 43,364 |
| MILANO VINCENT J Director | Conversion of Exercise of derivative security | May 31, 2024 | 12,523 |
| MOLINEAUX CHRISTOPHER P Director | Conversion of Exercise of derivative security | May 31, 2024 | 53,163 |
| POWELL ANDREW KENNETH WILLIAM Director | Conversion of Exercise of derivative security | May 31, 2024 | 33,523 |
| REASONS BRYAN M Director | Conversion of Exercise of derivative security | May 31, 2024 | 28,732 |
| SCHIFF ANDREW N Director | Conversion of Exercise of derivative security | May 31, 2024 | 443,622 |
| WALKER NEAL Chief Executive Officer | Conversion of Exercise of derivative security | Nov 1, 2024 | 1,376,390 |
Related Tickers
MYNZ Mainz Biomed N.V.
0.2387
-4.52%
STIM Neuronetics, Inc.
0.7100
-10.13%
NOTV Inotiv, Inc.
2.6800
-1.83%
PSNL Personalis, Inc.
3.8900
-9.53%
NDRA ENDRA Life Sciences Inc.
4.5400
-14.34%
PRE Prenetics Global Limited
4.5000
-5.26%
ENZ Enzo Biochem, Inc.
1.0400
0.00%
GENE Genetic Technologies Limited
0.7650
0.00%
VCYT Veracyte, Inc.
35.94
-2.97%
PRPO Precipio, Inc.
6.19
-0.77%